Dr. Andrew Ha pursued training in Cardiology and Cardiac Electrophysiology at the University of Ottawa Heart Institute and in Victoria, British Columbia. He completed a Master's degree in Clinical Epidemiology at the Harvard School of Public Health. Dr. Ha joined the Division of Cardiology at UHN in May 2011.
Dr. Ha's research is focused on the impact of arrhythmia therapies on patient-centered outcomes. In particular, he is interested in atrial fibrillation (AF), which is the most common heart rhythm condition encountered in clinical practice. Specifically, Dr. Ha studies the use of oral anticoagulation for AF-related stroke prevention, post-operative AF after cardiac surgery and AF ablation. Dr. Ha employs various research methods, including randomized clinical trials, "real-world" registries and administrative databases (big data) to generate clinically-relevant research that is useful for clinicians, patients and health policy makers.